Compare RYTM & NXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYTM | NXST |
|---|---|---|
| Founded | 2008 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Broadcasting |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 5.4B |
| IPO Year | 2017 | 2002 |
| Metric | RYTM | NXST |
|---|---|---|
| Price | $114.42 | $176.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 14 | 8 |
| Target Price | $131.14 | ★ $263.75 |
| AVG Volume (30 Days) | ★ 992.6K | 491.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.67% |
| EPS Growth | ★ 28.34 | N/A |
| EPS | N/A | ★ 5.09 |
| Revenue | N/A | ★ $4,949,000,000.00 |
| Revenue This Year | $55.34 | $11.38 |
| Revenue Next Year | $86.06 | N/A |
| P/E Ratio | ★ N/A | $35.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $74.50 | $154.47 |
| 52 Week High | $122.20 | $254.30 |
| Indicator | RYTM | NXST |
|---|---|---|
| Relative Strength Index (RSI) | 71.54 | 48.11 |
| Support Level | $98.30 | $154.47 |
| Resistance Level | $122.20 | $210.69 |
| Average True Range (ATR) | 4.86 | 7.99 |
| MACD | 0.94 | 2.19 |
| Stochastic Oscillator | 91.15 | 62.85 |
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.
Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Assuming its merger with Tegna is affirmed Nexstar's station total would exceed 259 and reach 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.